nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CYP3A4—Disulfiram—alcohol dependence	0.152	0.584	CbGbCtD
Maraviroc—CYP3A4—Citalopram—alcohol dependence	0.108	0.416	CbGbCtD
Maraviroc—CCR5—cardiovascular system—alcohol dependence	0.0142	0.182	CbGeAlD
Maraviroc—CCR5—Peptide GPCRs—OPRK1—alcohol dependence	0.0122	0.0485	CbGpPWpGaD
Maraviroc—CCR5—digestive system—alcohol dependence	0.0118	0.151	CbGeAlD
Maraviroc—CCR5—blood—alcohol dependence	0.0112	0.144	CbGeAlD
Maraviroc—CCR5—endocrine gland—alcohol dependence	0.00973	0.125	CbGeAlD
Maraviroc—CCR5—nervous system—alcohol dependence	0.00911	0.117	CbGeAlD
Maraviroc—CCR5—central nervous system—alcohol dependence	0.00877	0.113	CbGeAlD
Maraviroc—CCR5—Peptide GPCRs—OPRD1—alcohol dependence	0.00822	0.0326	CbGpPWpGaD
Maraviroc—CCR5—brain—alcohol dependence	0.00696	0.0895	CbGeAlD
Maraviroc—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.0064	0.0253	CbGpPWpGaD
Maraviroc—CCR5—Peptide GPCRs—OPRM1—alcohol dependence	0.00633	0.0251	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—CHRM2—alcohol dependence	0.00584	0.0231	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—OPRK1—alcohol dependence	0.00575	0.0228	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—OPRM1—alcohol dependence	0.00541	0.0214	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—OPRK1—alcohol dependence	0.00485	0.0192	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.0045	0.0178	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—DRD4—alcohol dependence	0.00416	0.0165	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.0041	0.0162	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—CNR1—alcohol dependence	0.00397	0.0157	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—HTR7—alcohol dependence	0.00388	0.0154	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—OPRD1—alcohol dependence	0.00387	0.0153	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.00386	0.0153	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—PDYN—alcohol dependence	0.00371	0.0147	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00339	0.0134	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—OPRD1—alcohol dependence	0.00326	0.0129	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—PDYN—alcohol dependence	0.00313	0.0124	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.00303	0.012	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—OPRM1—alcohol dependence	0.00298	0.0118	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—OPRK1—alcohol dependence	0.00294	0.0116	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00289	0.0114	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—NPY—alcohol dependence	0.00274	0.0108	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CHRM2—alcohol dependence	0.00273	0.0108	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—HTR2A—alcohol dependence	0.00272	0.0108	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00259	0.0103	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.00254	0.0101	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—OPRM1—alcohol dependence	0.00251	0.00994	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.00249	0.00985	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00245	0.00972	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.00233	0.00923	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—NPY—alcohol dependence	0.00231	0.00915	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—HTR1B—alcohol dependence	0.00223	0.00883	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.00217	0.00861	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00216	0.00855	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00215	0.00853	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.00207	0.00819	CbGpPWpGaD
Maraviroc—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00205	0.00812	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.002	0.00791	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—OPRD1—alcohol dependence	0.00198	0.00783	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—DRD4—alcohol dependence	0.00195	0.00772	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—PDYN—alcohol dependence	0.00189	0.0075	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CNR1—alcohol dependence	0.00186	0.00737	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.00184	0.00728	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—DRD2—alcohol dependence	0.00181	0.00719	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—AVP—alcohol dependence	0.00181	0.00717	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.00181	0.00716	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.00177	0.00702	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CRHR1—alcohol dependence	0.00176	0.00697	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.00173	0.00684	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.00168	0.00667	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.00168	0.00667	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—OPRK1—alcohol dependence	0.00166	0.00658	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CHRM2—alcohol dependence	0.00166	0.00656	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.00155	0.00614	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—OPRM1—alcohol dependence	0.00152	0.00602	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00152	0.00601	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—OPRK1—alcohol dependence	0.00151	0.00598	CbGpPWpGaD
Maraviroc—Herpes zoster—Citalopram—alcohol dependence	0.0015	0.00365	CcSEcCtD
Maraviroc—Sleep disorder—Naltrexone—alcohol dependence	0.00149	0.00363	CcSEcCtD
Maraviroc—Scotoma—Citalopram—alcohol dependence	0.00148	0.00362	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.00148	0.00586	CbGpPWpGaD
Maraviroc—Renal failure acute—Acamprosate—alcohol dependence	0.00148	0.0036	CcSEcCtD
Maraviroc—Amnesia—Acamprosate—alcohol dependence	0.00145	0.00354	CcSEcCtD
Maraviroc—Otitis media—Citalopram—alcohol dependence	0.00145	0.00353	CcSEcCtD
Maraviroc—Coagulopathy—Citalopram—alcohol dependence	0.00145	0.00353	CcSEcCtD
Maraviroc—Dermatitis exfoliative—Acamprosate—alcohol dependence	0.00145	0.00352	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.00144	0.00572	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.00144	0.00572	CbGpPWpGaD
Maraviroc—Nasal congestion—Naltrexone—alcohol dependence	0.00142	0.00345	CcSEcCtD
Maraviroc—Myocardial ischaemia—Citalopram—alcohol dependence	0.0014	0.00342	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—NPY—alcohol dependence	0.0014	0.00554	CbGpPWpGaD
Maraviroc—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.00137	0.00334	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—HTR1B—alcohol dependence	0.00135	0.00535	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CRH—alcohol dependence	0.00135	0.00535	CbGpPWpGaD
Maraviroc—Purpura—Naltrexone—alcohol dependence	0.00134	0.00326	CcSEcCtD
Maraviroc—Acne—Citalopram—alcohol dependence	0.00134	0.00326	CcSEcCtD
Maraviroc—Rhabdomyolysis—Citalopram—alcohol dependence	0.00127	0.0031	CcSEcCtD
Maraviroc—Rectal haemorrhage—Citalopram—alcohol dependence	0.00125	0.00304	CcSEcCtD
Maraviroc—Orthostatic hypotension—Acamprosate—alcohol dependence	0.00125	0.00304	CcSEcCtD
Maraviroc—Hyperbilirubinaemia—Citalopram—alcohol dependence	0.00124	0.00302	CcSEcCtD
Maraviroc—Breast disorder—Acamprosate—alcohol dependence	0.00123	0.003	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00123	0.00299	CcSEcCtD
Maraviroc—Herpes simplex—Citalopram—alcohol dependence	0.00122	0.00298	CcSEcCtD
Maraviroc—Oliguria—Citalopram—alcohol dependence	0.00122	0.00298	CcSEcCtD
Maraviroc—Paraesthesia—Disulfiram—alcohol dependence	0.00122	0.00298	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.00121	0.00481	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00121	0.0048	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—POMC—alcohol dependence	0.0012	0.00477	CbGpPWpGaD
Maraviroc—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.0012	0.00293	CcSEcCtD
Maraviroc—CYP3A4—digestive system—alcohol dependence	0.00119	0.0153	CbGeAlD
Maraviroc—Abdominal distension—Acamprosate—alcohol dependence	0.00119	0.00289	CcSEcCtD
Maraviroc—Cataract—Citalopram—alcohol dependence	0.00118	0.00288	CcSEcCtD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.00118	0.00467	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—DRD4—alcohol dependence	0.00118	0.00467	CbGpPWpGaD
Maraviroc—Influenza—Acamprosate—alcohol dependence	0.00118	0.00287	CcSEcCtD
Maraviroc—Abdominal pain upper—Naltrexone—alcohol dependence	0.00118	0.00287	CcSEcCtD
Maraviroc—Fatigue—Disulfiram—alcohol dependence	0.00117	0.00286	CcSEcCtD
Maraviroc—Eosinophilia—Acamprosate—alcohol dependence	0.00117	0.00285	CcSEcCtD
Maraviroc—Pain—Disulfiram—alcohol dependence	0.00116	0.00284	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00116	0.00283	CcSEcCtD
Maraviroc—Pancreatitis—Acamprosate—alcohol dependence	0.00116	0.00282	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00115	0.00457	CbGpPWpGaD
Maraviroc—Nasopharyngitis—Naltrexone—alcohol dependence	0.00115	0.00281	CcSEcCtD
Maraviroc—Angina pectoris—Acamprosate—alcohol dependence	0.00115	0.0028	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00114	0.00277	CcSEcCtD
Maraviroc—Bronchitis—Acamprosate—alcohol dependence	0.00113	0.00276	CcSEcCtD
Maraviroc—CYP3A4—blood—alcohol dependence	0.00113	0.0146	CbGeAlD
Maraviroc—CCR5—GPCR ligand binding—CNR1—alcohol dependence	0.00113	0.00446	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—OPRD1—alcohol dependence	0.00112	0.00442	CbGpPWpGaD
Maraviroc—Influenza—Naltrexone—alcohol dependence	0.00112	0.00272	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—HTR7—alcohol dependence	0.0011	0.00435	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—DRD2—alcohol dependence	0.0011	0.00435	CbGpPWpGaD
Maraviroc—Influenza like illness—Citalopram—alcohol dependence	0.00109	0.00267	CcSEcCtD
Maraviroc—Angina pectoris—Naltrexone—alcohol dependence	0.00109	0.00265	CcSEcCtD
Maraviroc—Colitis—Citalopram—alcohol dependence	0.00108	0.00264	CcSEcCtD
Maraviroc—Bronchitis—Naltrexone—alcohol dependence	0.00107	0.00262	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—PDYN—alcohol dependence	0.00107	0.00424	CbGpPWpGaD
Maraviroc—Pneumonia—Acamprosate—alcohol dependence	0.00106	0.00258	CcSEcCtD
Maraviroc—Depression—Acamprosate—alcohol dependence	0.00105	0.00256	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00104	0.00253	CcSEcCtD
Maraviroc—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00104	0.00253	CcSEcCtD
Maraviroc—Myocardial infarction—Acamprosate—alcohol dependence	0.00103	0.00251	CcSEcCtD
Maraviroc—Stomatitis—Acamprosate—alcohol dependence	0.00102	0.0025	CcSEcCtD
Maraviroc—Urine output increased—Citalopram—alcohol dependence	0.00102	0.00248	CcSEcCtD
Maraviroc—Neoplasm—Citalopram—alcohol dependence	0.00102	0.00248	CcSEcCtD
Maraviroc—CCR5—G alpha (i) signalling events—POMC—alcohol dependence	0.00102	0.00402	CbGpPWpGaD
Maraviroc—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.00101	0.00402	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—OPRD1—alcohol dependence	0.00101	0.00402	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.00101	0.004	CbGpPWpGaD
Maraviroc—Pneumonia—Naltrexone—alcohol dependence	0.001	0.00244	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CRHR1—alcohol dependence	0.000995	0.00394	CbGpPWpGaD
Maraviroc—Infestation—Naltrexone—alcohol dependence	0.000994	0.00242	CcSEcCtD
Maraviroc—Infestation NOS—Naltrexone—alcohol dependence	0.000994	0.00242	CcSEcCtD
Maraviroc—Depression—Naltrexone—alcohol dependence	0.000991	0.00242	CcSEcCtD
Maraviroc—CYP3A4—endocrine gland—alcohol dependence	0.000981	0.0126	CbGeAlD
Maraviroc—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00098	0.00239	CcSEcCtD
Maraviroc—Asthenia—Disulfiram—alcohol dependence	0.000976	0.00238	CcSEcCtD
Maraviroc—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000975	0.00386	CbGpPWpGaD
Maraviroc—Myocardial infarction—Naltrexone—alcohol dependence	0.000975	0.00238	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—PDYN—alcohol dependence	0.000972	0.00385	CbGpPWpGaD
Maraviroc—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00097	0.00384	CbGpPWpGaD
Maraviroc—Conjunctivitis—Naltrexone—alcohol dependence	0.000966	0.00236	CcSEcCtD
Maraviroc—Lymphadenopathy—Citalopram—alcohol dependence	0.000958	0.00234	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000956	0.00379	CbGpPWpGaD
Maraviroc—Rhinitis—Acamprosate—alcohol dependence	0.000946	0.00231	CcSEcCtD
Maraviroc—Sleep disorder—Citalopram—alcohol dependence	0.000944	0.0023	CcSEcCtD
Maraviroc—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00094	0.00229	CcSEcCtD
Maraviroc—Diabetes mellitus—Citalopram—alcohol dependence	0.00094	0.00229	CcSEcCtD
Maraviroc—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.00094	0.00229	CcSEcCtD
Maraviroc—Hallucination—Acamprosate—alcohol dependence	0.000939	0.00229	CcSEcCtD
Maraviroc—Pharyngitis—Acamprosate—alcohol dependence	0.000936	0.00228	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CHRM2—alcohol dependence	0.000936	0.00371	CbGpPWpGaD
Maraviroc—Sinusitis—Naltrexone—alcohol dependence	0.000933	0.00227	CcSEcCtD
Maraviroc—Polyuria—Citalopram—alcohol dependence	0.000931	0.00227	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—AVP—alcohol dependence	0.000925	0.00366	CbGpPWpGaD
Maraviroc—CYP3A4—nervous system—alcohol dependence	0.000919	0.0118	CbGeAlD
Maraviroc—Deafness—Citalopram—alcohol dependence	0.000914	0.00223	CcSEcCtD
Maraviroc—Vascular purpura—Citalopram—alcohol dependence	0.000914	0.00223	CcSEcCtD
Maraviroc—Eczema—Citalopram—alcohol dependence	0.00091	0.00222	CcSEcCtD
Maraviroc—Hepatic failure—Citalopram—alcohol dependence	0.00091	0.00222	CcSEcCtD
Maraviroc—Haemolytic anaemia—Citalopram—alcohol dependence	0.000905	0.00221	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CRHR1—alcohol dependence	0.000904	0.00358	CbGpPWpGaD
Maraviroc—Dizziness—Disulfiram—alcohol dependence	0.0009	0.00219	CcSEcCtD
Maraviroc—Nasal congestion—Citalopram—alcohol dependence	0.000897	0.00219	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—OPRK1—alcohol dependence	0.000891	0.00353	CbGpPWpGaD
Maraviroc—Hallucination—Naltrexone—alcohol dependence	0.000888	0.00217	CcSEcCtD
Maraviroc—Pharyngitis—Naltrexone—alcohol dependence	0.000886	0.00216	CcSEcCtD
Maraviroc—Renal failure acute—Citalopram—alcohol dependence	0.000885	0.00216	CcSEcCtD
Maraviroc—CYP3A4—liver—alcohol dependence	0.000885	0.0114	CbGeAlD
Maraviroc—CYP3A4—central nervous system—alcohol dependence	0.000884	0.0114	CbGeAlD
Maraviroc—Connective tissue disorder—Naltrexone—alcohol dependence	0.000877	0.00214	CcSEcCtD
Maraviroc—Amnesia—Citalopram—alcohol dependence	0.00087	0.00212	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—OPRM1—alcohol dependence	0.000859	0.0034	CbGpPWpGaD
Maraviroc—Rash—Disulfiram—alcohol dependence	0.000858	0.00209	CcSEcCtD
Maraviroc—Headache—Disulfiram—alcohol dependence	0.000852	0.00208	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CHRM2—alcohol dependence	0.00085	0.00337	CbGpPWpGaD
Maraviroc—Purpura—Citalopram—alcohol dependence	0.000848	0.00207	CcSEcCtD
Maraviroc—Cerebrovascular accident—Citalopram—alcohol dependence	0.000834	0.00203	CcSEcCtD
Maraviroc—Eye disorder—Naltrexone—alcohol dependence	0.000834	0.00203	CcSEcCtD
Maraviroc—Alopecia—Acamprosate—alcohol dependence	0.000834	0.00203	CcSEcCtD
Maraviroc—Cardiac disorder—Naltrexone—alcohol dependence	0.000828	0.00202	CcSEcCtD
Maraviroc—Mental disorder—Acamprosate—alcohol dependence	0.000826	0.00202	CcSEcCtD
Maraviroc—Malnutrition—Acamprosate—alcohol dependence	0.000821	0.002	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000813	0.00322	CbGpPWpGaD
Maraviroc—Angiopathy—Naltrexone—alcohol dependence	0.00081	0.00197	CcSEcCtD
Maraviroc—Flatulence—Acamprosate—alcohol dependence	0.000809	0.00197	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000807	0.0032	CbGpPWpGaD
Maraviroc—Mediastinal disorder—Naltrexone—alcohol dependence	0.000804	0.00196	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—NPY—alcohol dependence	0.00079	0.00313	CbGpPWpGaD
Maraviroc—Alopecia—Naltrexone—alcohol dependence	0.000789	0.00192	CcSEcCtD
Maraviroc—Mental disorder—Naltrexone—alcohol dependence	0.000782	0.00191	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—OPRM1—alcohol dependence	0.00078	0.00309	CbGpPWpGaD
Maraviroc—Malnutrition—Naltrexone—alcohol dependence	0.000777	0.00189	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—HTR2A—alcohol dependence	0.00077	0.00305	CbGpPWpGaD
Maraviroc—Tremor—Acamprosate—alcohol dependence	0.000769	0.00188	CcSEcCtD
Maraviroc—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000766	0.00303	CbGpPWpGaD
Maraviroc—Flatulence—Naltrexone—alcohol dependence	0.000766	0.00187	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CRH—alcohol dependence	0.000763	0.00302	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR1B—alcohol dependence	0.000763	0.00302	CbGpPWpGaD
Maraviroc—Anaemia—Acamprosate—alcohol dependence	0.000759	0.00185	CcSEcCtD
Maraviroc—Orthostatic hypotension—Citalopram—alcohol dependence	0.000747	0.00182	CcSEcCtD
Maraviroc—Abdominal pain upper—Citalopram—alcohol dependence	0.000747	0.00182	CcSEcCtD
Maraviroc—Breast disorder—Citalopram—alcohol dependence	0.000739	0.0018	CcSEcCtD
Maraviroc—Syncope—Acamprosate—alcohol dependence	0.000736	0.0018	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000736	0.0018	CcSEcCtD
Maraviroc—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000736	0.0018	CcSEcCtD
Maraviroc—Leukopenia—Acamprosate—alcohol dependence	0.000735	0.00179	CcSEcCtD
Maraviroc—Nasopharyngitis—Citalopram—alcohol dependence	0.000731	0.00178	CcSEcCtD
Maraviroc—Tremor—Naltrexone—alcohol dependence	0.000728	0.00178	CcSEcCtD
Maraviroc—Loss of consciousness—Acamprosate—alcohol dependence	0.000722	0.00176	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000721	0.00176	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—NPY—alcohol dependence	0.000718	0.00284	CbGpPWpGaD
Maraviroc—Cough—Acamprosate—alcohol dependence	0.000717	0.00175	CcSEcCtD
Maraviroc—Convulsion—Acamprosate—alcohol dependence	0.000711	0.00174	CcSEcCtD
Maraviroc—Abdominal distension—Citalopram—alcohol dependence	0.000711	0.00173	CcSEcCtD
Maraviroc—Influenza—Citalopram—alcohol dependence	0.000706	0.00172	CcSEcCtD
Maraviroc—Eosinophilia—Citalopram—alcohol dependence	0.0007	0.00171	CcSEcCtD
Maraviroc—Myalgia—Acamprosate—alcohol dependence	0.000699	0.0017	CcSEcCtD
Maraviroc—Syncope—Naltrexone—alcohol dependence	0.000697	0.0017	CcSEcCtD
Maraviroc—Anxiety—Acamprosate—alcohol dependence	0.000697	0.0017	CcSEcCtD
Maraviroc—Bronchospasm—Citalopram—alcohol dependence	0.000695	0.00169	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000694	0.00169	CcSEcCtD
Maraviroc—Pancreatitis—Citalopram—alcohol dependence	0.000693	0.00169	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CRH—alcohol dependence	0.000693	0.00274	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR1B—alcohol dependence	0.000693	0.00274	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000691	0.00274	CbGpPWpGaD
Maraviroc—Discomfort—Acamprosate—alcohol dependence	0.000691	0.00168	CcSEcCtD
Maraviroc—Angina pectoris—Citalopram—alcohol dependence	0.000688	0.00168	CcSEcCtD
Maraviroc—Loss of consciousness—Naltrexone—alcohol dependence	0.000683	0.00167	CcSEcCtD
Maraviroc—Bronchitis—Citalopram—alcohol dependence	0.000679	0.00166	CcSEcCtD
Maraviroc—Cough—Naltrexone—alcohol dependence	0.000678	0.00165	CcSEcCtD
Maraviroc—Convulsion—Naltrexone—alcohol dependence	0.000673	0.00164	CcSEcCtD
Maraviroc—Pancytopenia—Citalopram—alcohol dependence	0.000671	0.00164	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—DRD4—alcohol dependence	0.000667	0.00264	CbGpPWpGaD
Maraviroc—Infection—Acamprosate—alcohol dependence	0.000666	0.00162	CcSEcCtD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000663	0.00263	CbGpPWpGaD
Maraviroc—Myalgia—Naltrexone—alcohol dependence	0.000661	0.00161	CcSEcCtD
Maraviroc—Shock—Acamprosate—alcohol dependence	0.000659	0.00161	CcSEcCtD
Maraviroc—Anxiety—Naltrexone—alcohol dependence	0.000659	0.00161	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000657	0.0016	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000657	0.0016	CcSEcCtD
Maraviroc—Discomfort—Naltrexone—alcohol dependence	0.000654	0.00159	CcSEcCtD
Maraviroc—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000651	0.00258	CbGpPWpGaD
Maraviroc—Skin disorder—Acamprosate—alcohol dependence	0.000651	0.00159	CcSEcCtD
Maraviroc—Anorexia—Acamprosate—alcohol dependence	0.000639	0.00156	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CNR1—alcohol dependence	0.000637	0.00252	CbGpPWpGaD
Maraviroc—Oedema—Naltrexone—alcohol dependence	0.000634	0.00155	CcSEcCtD
Maraviroc—Pneumonia—Citalopram—alcohol dependence	0.000634	0.00155	CcSEcCtD
Maraviroc—Infection—Naltrexone—alcohol dependence	0.00063	0.00154	CcSEcCtD
Maraviroc—Infestation NOS—Citalopram—alcohol dependence	0.00063	0.00154	CcSEcCtD
Maraviroc—Infestation—Citalopram—alcohol dependence	0.00063	0.00154	CcSEcCtD
Maraviroc—Depression—Citalopram—alcohol dependence	0.000628	0.00153	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000625	0.00152	CcSEcCtD
Maraviroc—Shock—Naltrexone—alcohol dependence	0.000624	0.00152	CcSEcCtD
Maraviroc—Nervous system disorder—Naltrexone—alcohol dependence	0.000622	0.00152	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—DRD2—alcohol dependence	0.000621	0.00246	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR7—alcohol dependence	0.000621	0.00246	CbGpPWpGaD
Maraviroc—Acute coronary syndrome—Citalopram—alcohol dependence	0.000621	0.00151	CcSEcCtD
Maraviroc—Myocardial infarction—Citalopram—alcohol dependence	0.000617	0.00151	CcSEcCtD
Maraviroc—Neuropathy peripheral—Citalopram—alcohol dependence	0.000617	0.00151	CcSEcCtD
Maraviroc—Skin disorder—Naltrexone—alcohol dependence	0.000616	0.0015	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—POMC—alcohol dependence	0.000615	0.00243	CbGpPWpGaD
Maraviroc—Stomatitis—Citalopram—alcohol dependence	0.000614	0.0015	CcSEcCtD
Maraviroc—Jaundice—Citalopram—alcohol dependence	0.000614	0.0015	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000613	0.00243	CbGpPWpGaD
Maraviroc—Conjunctivitis—Citalopram—alcohol dependence	0.000612	0.00149	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000611	0.00149	CcSEcCtD
Maraviroc—Insomnia—Acamprosate—alcohol dependence	0.000606	0.00148	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000606	0.0024	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—DRD4—alcohol dependence	0.000605	0.0024	CbGpPWpGaD
Maraviroc—Anorexia—Naltrexone—alcohol dependence	0.000604	0.00147	CcSEcCtD
Maraviroc—Paraesthesia—Acamprosate—alcohol dependence	0.000602	0.00147	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—OPRD1—alcohol dependence	0.000599	0.00237	CbGpPWpGaD
Maraviroc—Hepatobiliary disease—Citalopram—alcohol dependence	0.000596	0.00145	CcSEcCtD
Maraviroc—Sinusitis—Citalopram—alcohol dependence	0.000591	0.00144	CcSEcCtD
Maraviroc—Agranulocytosis—Citalopram—alcohol dependence	0.000588	0.00143	CcSEcCtD
Maraviroc—Decreased appetite—Acamprosate—alcohol dependence	0.000583	0.00142	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000579	0.00141	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CNR1—alcohol dependence	0.000578	0.00229	CbGpPWpGaD
Maraviroc—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000578	0.00141	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PDYN—alcohol dependence	0.000574	0.00227	CbGpPWpGaD
Maraviroc—Insomnia—Naltrexone—alcohol dependence	0.000573	0.0014	CcSEcCtD
Maraviroc—Constipation—Acamprosate—alcohol dependence	0.000573	0.0014	CcSEcCtD
Maraviroc—Pain—Acamprosate—alcohol dependence	0.000573	0.0014	CcSEcCtD
Maraviroc—Paraesthesia—Naltrexone—alcohol dependence	0.000569	0.00139	CcSEcCtD
Maraviroc—Rhinitis—Citalopram—alcohol dependence	0.000567	0.00138	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—HTR7—alcohol dependence	0.000564	0.00223	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—DRD2—alcohol dependence	0.000564	0.00223	CbGpPWpGaD
Maraviroc—Hallucination—Citalopram—alcohol dependence	0.000563	0.00137	CcSEcCtD
Maraviroc—Pharyngitis—Citalopram—alcohol dependence	0.000561	0.00137	CcSEcCtD
Maraviroc—Urinary tract disorder—Citalopram—alcohol dependence	0.000558	0.00136	CcSEcCtD
Maraviroc—Connective tissue disorder—Citalopram—alcohol dependence	0.000556	0.00136	CcSEcCtD
Maraviroc—Urethral disorder—Citalopram—alcohol dependence	0.000554	0.00135	CcSEcCtD
Maraviroc—Decreased appetite—Naltrexone—alcohol dependence	0.000551	0.00134	CcSEcCtD
Maraviroc—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000548	0.00134	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000547	0.00133	CcSEcCtD
Maraviroc—Fatigue—Naltrexone—alcohol dependence	0.000547	0.00133	CcSEcCtD
Maraviroc—Pain—Naltrexone—alcohol dependence	0.000542	0.00132	CcSEcCtD
Maraviroc—Constipation—Naltrexone—alcohol dependence	0.000542	0.00132	CcSEcCtD
Maraviroc—Erythema multiforme—Citalopram—alcohol dependence	0.000535	0.0013	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—WASF2—alcohol dependence	0.000534	0.00211	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CRHR1—alcohol dependence	0.000534	0.00211	CbGpPWpGaD
Maraviroc—Body temperature increased—Acamprosate—alcohol dependence	0.00053	0.00129	CcSEcCtD
Maraviroc—Abdominal pain—Acamprosate—alcohol dependence	0.00053	0.00129	CcSEcCtD
Maraviroc—Eye disorder—Citalopram—alcohol dependence	0.000528	0.00129	CcSEcCtD
Maraviroc—CCR5—Disease—GOT2—alcohol dependence	0.000528	0.00209	CbGpPWpGaD
Maraviroc—Cardiac disorder—Citalopram—alcohol dependence	0.000525	0.00128	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—AVP—alcohol dependence	0.000523	0.00207	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000521	0.00206	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000518	0.00126	CcSEcCtD
Maraviroc—Angiopathy—Citalopram—alcohol dependence	0.000513	0.00125	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—WASF1—alcohol dependence	0.000512	0.00203	CbGpPWpGaD
Maraviroc—Mediastinal disorder—Citalopram—alcohol dependence	0.00051	0.00124	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000508	0.00201	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000502	0.00199	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CHRM2—alcohol dependence	0.000502	0.00199	CbGpPWpGaD
Maraviroc—Body temperature increased—Naltrexone—alcohol dependence	0.000501	0.00122	CcSEcCtD
Maraviroc—Abdominal pain—Naltrexone—alcohol dependence	0.000501	0.00122	CcSEcCtD
Maraviroc—Alopecia—Citalopram—alcohol dependence	0.0005	0.00122	CcSEcCtD
Maraviroc—Mental disorder—Citalopram—alcohol dependence	0.000495	0.00121	CcSEcCtD
Maraviroc—Hypersensitivity—Acamprosate—alcohol dependence	0.000494	0.0012	CcSEcCtD
Maraviroc—Malnutrition—Citalopram—alcohol dependence	0.000492	0.0012	CcSEcCtD
Maraviroc—Erythema—Citalopram—alcohol dependence	0.000492	0.0012	CcSEcCtD
Maraviroc—Flatulence—Citalopram—alcohol dependence	0.000485	0.00118	CcSEcCtD
Maraviroc—Asthenia—Acamprosate—alcohol dependence	0.000481	0.00117	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—AVP—alcohol dependence	0.000475	0.00188	CbGpPWpGaD
Maraviroc—Pruritus—Acamprosate—alcohol dependence	0.000474	0.00116	CcSEcCtD
Maraviroc—Hypersensitivity—Naltrexone—alcohol dependence	0.000467	0.00114	CcSEcCtD
Maraviroc—Tremor—Citalopram—alcohol dependence	0.000461	0.00112	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—OPRM1—alcohol dependence	0.000461	0.00183	CbGpPWpGaD
Maraviroc—Diarrhoea—Acamprosate—alcohol dependence	0.000459	0.00112	CcSEcCtD
Maraviroc—CCR5—Disease—GOT1—alcohol dependence	0.000456	0.00181	CbGpPWpGaD
Maraviroc—Anaemia—Citalopram—alcohol dependence	0.000455	0.00111	CcSEcCtD
Maraviroc—Asthenia—Naltrexone—alcohol dependence	0.000455	0.00111	CcSEcCtD
Maraviroc—Pruritus—Naltrexone—alcohol dependence	0.000449	0.00109	CcSEcCtD
Maraviroc—Dizziness—Acamprosate—alcohol dependence	0.000443	0.00108	CcSEcCtD
Maraviroc—Syncope—Citalopram—alcohol dependence	0.000441	0.00108	CcSEcCtD
Maraviroc—Leukopenia—Citalopram—alcohol dependence	0.000441	0.00107	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—HTR2A—alcohol dependence	0.000435	0.00172	CbGpPWpGaD
Maraviroc—Diarrhoea—Naltrexone—alcohol dependence	0.000434	0.00106	CcSEcCtD
Maraviroc—Loss of consciousness—Citalopram—alcohol dependence	0.000433	0.00106	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000432	0.00171	CbGpPWpGaD
Maraviroc—Cough—Citalopram—alcohol dependence	0.00043	0.00105	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000427	0.00169	CbGpPWpGaD
Maraviroc—Convulsion—Citalopram—alcohol dependence	0.000427	0.00104	CcSEcCtD
Maraviroc—Vomiting—Acamprosate—alcohol dependence	0.000426	0.00104	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—NPY—alcohol dependence	0.000424	0.00168	CbGpPWpGaD
Maraviroc—Rash—Acamprosate—alcohol dependence	0.000423	0.00103	CcSEcCtD
Maraviroc—Dermatitis—Acamprosate—alcohol dependence	0.000422	0.00103	CcSEcCtD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000421	0.00167	CbGpPWpGaD
Maraviroc—Headache—Acamprosate—alcohol dependence	0.00042	0.00102	CcSEcCtD
Maraviroc—Dizziness—Naltrexone—alcohol dependence	0.000419	0.00102	CcSEcCtD
Maraviroc—Myalgia—Citalopram—alcohol dependence	0.000419	0.00102	CcSEcCtD
Maraviroc—Anxiety—Citalopram—alcohol dependence	0.000418	0.00102	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000416	0.00101	CcSEcCtD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000416	0.00165	CbGpPWpGaD
Maraviroc—Discomfort—Citalopram—alcohol dependence	0.000414	0.00101	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HTR1B—alcohol dependence	0.000409	0.00162	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CRH—alcohol dependence	0.000409	0.00162	CbGpPWpGaD
Maraviroc—Vomiting—Naltrexone—alcohol dependence	0.000403	0.000983	CcSEcCtD
Maraviroc—Oedema—Citalopram—alcohol dependence	0.000402	0.00098	CcSEcCtD
Maraviroc—Rash—Naltrexone—alcohol dependence	0.0004	0.000975	CcSEcCtD
Maraviroc—Dermatitis—Naltrexone—alcohol dependence	0.000399	0.000974	CcSEcCtD
Maraviroc—Infection—Citalopram—alcohol dependence	0.000399	0.000973	CcSEcCtD
Maraviroc—Nausea—Acamprosate—alcohol dependence	0.000398	0.000971	CcSEcCtD
Maraviroc—Headache—Naltrexone—alcohol dependence	0.000397	0.000969	CcSEcCtD
Maraviroc—Shock—Citalopram—alcohol dependence	0.000395	0.000964	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—HTR2A—alcohol dependence	0.000395	0.00156	CbGpPWpGaD
Maraviroc—Nervous system disorder—Citalopram—alcohol dependence	0.000394	0.000961	CcSEcCtD
Maraviroc—Skin disorder—Citalopram—alcohol dependence	0.00039	0.000952	CcSEcCtD
Maraviroc—Anorexia—Citalopram—alcohol dependence	0.000383	0.000934	CcSEcCtD
Maraviroc—Nausea—Naltrexone—alcohol dependence	0.000377	0.000918	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000367	0.00145	CbGpPWpGaD
Maraviroc—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000366	0.000893	CcSEcCtD
Maraviroc—Insomnia—Citalopram—alcohol dependence	0.000363	0.000886	CcSEcCtD
Maraviroc—Paraesthesia—Citalopram—alcohol dependence	0.000361	0.00088	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—DRD4—alcohol dependence	0.000358	0.00142	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000352	0.00139	CbGpPWpGaD
Maraviroc—Decreased appetite—Citalopram—alcohol dependence	0.000349	0.000852	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—POMC—alcohol dependence	0.000347	0.00138	CbGpPWpGaD
Maraviroc—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000347	0.000846	CcSEcCtD
Maraviroc—Fatigue—Citalopram—alcohol dependence	0.000346	0.000845	CcSEcCtD
Maraviroc—Constipation—Citalopram—alcohol dependence	0.000344	0.000838	CcSEcCtD
Maraviroc—Pain—Citalopram—alcohol dependence	0.000344	0.000838	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CNR1—alcohol dependence	0.000341	0.00135	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000341	0.00135	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR7—alcohol dependence	0.000333	0.00132	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DRD2—alcohol dependence	0.000333	0.00132	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Citalopram—alcohol dependence	0.000329	0.000801	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000322	0.00128	CbGpPWpGaD
Maraviroc—Body temperature increased—Citalopram—alcohol dependence	0.000318	0.000775	CcSEcCtD
Maraviroc—Abdominal pain—Citalopram—alcohol dependence	0.000318	0.000775	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—POMC—alcohol dependence	0.000315	0.00125	CbGpPWpGaD
Maraviroc—Hypersensitivity—Citalopram—alcohol dependence	0.000296	0.000722	CcSEcCtD
Maraviroc—Asthenia—Citalopram—alcohol dependence	0.000288	0.000703	CcSEcCtD
Maraviroc—Pruritus—Citalopram—alcohol dependence	0.000284	0.000693	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000281	0.00111	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AVP—alcohol dependence	0.00028	0.00111	CbGpPWpGaD
Maraviroc—Diarrhoea—Citalopram—alcohol dependence	0.000275	0.00067	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000267	0.00106	CbGpPWpGaD
Maraviroc—Dizziness—Citalopram—alcohol dependence	0.000266	0.000648	CcSEcCtD
Maraviroc—Vomiting—Citalopram—alcohol dependence	0.000255	0.000623	CcSEcCtD
Maraviroc—Rash—Citalopram—alcohol dependence	0.000253	0.000618	CcSEcCtD
Maraviroc—Dermatitis—Citalopram—alcohol dependence	0.000253	0.000617	CcSEcCtD
Maraviroc—Headache—Citalopram—alcohol dependence	0.000252	0.000614	CcSEcCtD
Maraviroc—Nausea—Citalopram—alcohol dependence	0.000239	0.000582	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HTR2A—alcohol dependence	0.000233	0.000924	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000227	0.000898	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000226	0.000893	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—POMC—alcohol dependence	0.000186	0.000738	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000183	0.000724	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000181	0.000718	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000179	0.000708	CbGpPWpGaD
Maraviroc—CCR5—Disease—EP300—alcohol dependence	0.000177	0.000699	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000166	0.000659	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000149	0.000591	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EP300—alcohol dependence	0.000124	0.00049	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADH6—alcohol dependence	0.000105	0.000415	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—POMC—alcohol dependence	9.71e-05	0.000385	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADH1A—alcohol dependence	8.68e-05	0.000344	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADH4—alcohol dependence	7.38e-05	0.000292	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADH7—alcohol dependence	6.28e-05	0.000249	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GGT2—alcohol dependence	6.02e-05	0.000238	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADH1B—alcohol dependence	5.51e-05	0.000218	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MAOB—alcohol dependence	4.56e-05	0.000181	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDH2—alcohol dependence	3.88e-05	0.000154	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GOT2—alcohol dependence	3.3e-05	0.000131	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2E1—alcohol dependence	3.1e-05	0.000123	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GGT1—alcohol dependence	2.85e-05	0.000113	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GOT1—alcohol dependence	2.85e-05	0.000113	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MAOA—alcohol dependence	2.55e-05	0.000101	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—POMC—alcohol dependence	1.66e-05	6.58e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—EP300—alcohol dependence	1.1e-05	4.36e-05	CbGpPWpGaD
